Advances in Local and Systemic Therapies for Hepatocellular Cancer

Current Oncology Reports
Ali A MokdadAdam C Yopp

Abstract

Global incidence and mortality of hepatocellular carcinoma (HCC) has increased over the past two decades. Although transplantation and surgical resection offer a chance for cure and long-term survival, most patients present with more advanced tumor stage when these therapies are not possible. Although rarely curative, locoregional therapy with transarterial chemoembolization or radioembolization offers a survival benefit for those with liver-isolated HCC who are not amenable to curative therapies. Patients with metastatic disease or macrovascular invasion are treated with systemic therapy; however, median survival remains below 1 year. Patients with severe liver dysfunction or poor performance status should be treated with best supportive care given poor prognosis and no survival benefit for treatment. Lack of predictive and prognostic biomarkers in intermediate and advanced HCC tumors has hampered integration of clinical and molecular data to aid tailoring treatment decisions. However, with increasingly complex treatment decisions, optimal outcomes are achieved through multidisciplinary care.

References

Jan 1, 1981·Cancer·A B MillerA Winkler
May 11, 1995·The New England Journal of Medicine·UNKNOWN Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Nov 20, 1998·The American Journal of Gastroenterology·T KaizuT Kumazaki
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Oct 31, 2001·Seminars in Oncology·T W Leung, P J Johnson
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Oct 28, 2004·Gastroenterology·Jordi BruixJosep M Llovet
May 26, 2005·International Journal of Radiation Oncology, Biology, Physics·Zhao-Chong ZengJian-Hua Wang
May 27, 2005·Seminars in Liver Disease·Josep M LlovetVincenzo Mazzaferro
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip A PhilipCharles Erlichman
Jul 12, 2007·Cancer·Melanie B ThomasJames L Abbruzzese
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ignacio DuranLillian L Siu
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuRakesh K Jain
Nov 13, 2009·Cardiovascular and Interventional Radiology·Johannes LammerUNKNOWN PRECISION V Investigators
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Feb 23, 2010·Seminars in Liver Disease·Alejandro FornerJordi Bruix
Nov 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philip HilgardGerald Antoch
Mar 18, 2011·The Cochrane Database of Systematic Reviews·Roberto S OliveriChristian Gluud
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bruno SangroUNKNOWN European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY)
Jun 15, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Masatoshi KudoKiwamu Okita
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy M PawlikJean-Francois H Geschwind
Jan 13, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard S FinnJoong-Won Park
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Aug 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vincenzo MazzaferroCarlo Spreafico

❮ Previous
Next ❯

Citations

Apr 6, 2017·Luminescence : the Journal of Biological and Chemical Luminescence·Afnan H ZawanehHadir M Maher
Aug 1, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Samuel John FahrenholtzErik Cressman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Hepatology
Carlos Rodríguez de LopeJordi Bruix
La Revue du praticien
Jean-Luc RaoulMarc Giovannini
Langenbecks Archiv für Chirurgie. Supplement. Kongressband
T GebauerH Lippert
© 2022 Meta ULC. All rights reserved